Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
511 Effect of Transcranial Direct Current Stimulation of the Motor Cortex on Visceral Pain in Patients with Hepatocellular Carcinoma. Department of Anesthesia, Intensive care and Pain management Dr. Shereen Mamdoh Mohamed kamal 2018
512 Downregulation of regulatory T cells in patients with chronic obstructive pulmonary disease: relation to disease severity Department of Clinical Pathology Dr. Noha gaber sayed 2018
513 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2018
514 Does Simple Oral Route of Administration Affect Acute Post Operative Pain?(Oral Pregabalin Versus Oral Morphine Sulphate) for Acute Post Operative Pain following Cancer Surgeries Department of Anesthesia, Intensive care and Pain management Ahmed ahmed ibrahem ahmed 2018
515 Significant correlation between regulatory T cells and vitamin D status in
term and preterm labor
 		Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2018
516 PO-094: HCMV Among Pediatrics Acute Lymphoblastic Leukemia Patients in South Egypt Cancer Institute Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2018
517 1. Concurrent Use of Capecitabine with Adjuvant
Radiotherapy in the Treatment of Patients with Breast
Cancer
 		Department of Radiotherapy and Nuclear medicine Dr. Ayat allah Ali yousseif 2018
518 Comparison of nebulised dexmedetomidine,
ketamine, or midazolam for premedication in
preschool children undergoing bone marrow biopsy 		Department of Anesthesia, Intensive care and Pain management Prof. Sahar Abdel Baky Mohamed Ahmad 2018
519 Effect of Intrathecally Administered Ketamine, Morphine, and Their Combination Added to Bupivacaine in Patients Undergoing Major Abdominal Cancer Surgery a Randomized, Double-Blind Study Department of Anesthesia, Intensive care and Pain management Dr. Ahmad Mohammad Abd El-Rahman 2018
520 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom
 		Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2018